Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency

Journal of Immunology

Volumn 174, Issue 8, 2005, Pages 5074-5081

  Isgrò, Antonella ^a   Marziali, Marco ^a   Mezzaroma, Ivano ^a   Luzi, Giuseppe ^b   Mazzone, Anna Maria ^a   Guazzi, Vanessa ^a   Andolfi, Grazia ^c   Cassani, Barbara ^c   Aiuti, Alessandro ^c   Aiuti, Fernando ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL CULTURE; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING CELL; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ERYTHROID CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; STROMA CELL; THYMUS;

EID: 20144387298     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.8.5074     Document Type: Article

References (37)

1. International Union of Immunological Societies. 1999. Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin. Exp. Immunol. 118:1.
2. Conley, M. E., and E. R. Stiehm. 1996. Immunodeficiency disorders. In Immunologic Disorders of Infants and Children. W. B. Saunders, New York, p. 201.
3. Cunningham-Rundles, C., F. P. Siegal, S. Cunningham-Rundles, and P. Lieberman. 1987. Incidence of cancer in 98 patients with common varied immunodeficiency. J. Clin. Immunol. 7:294.
4. Muscaritoli, M., F. Fanfarillo, G. Luzi, M. C. Sirianni, F. Iebba, A. Laviano, M. Russo, F. Aiuti, and F. Rossi Fanelli. 2001. Impaired nutritional status in CVID patients correlates with reduced levels of serum IgA and of circulating CD4 T lymphocytes. Eur. J. Clin. Invest. 31:544.
5. Cunningham-Rundles, and C., C. Bodian. 1999. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92:34.
6. Stagg, A. J., M. Funauchi, S. C. Knight, A. D. B. Webster, and J. Farrant. 1994. Failure in antigen responses by T cells from patients with common variable immunodeficiency. Clin. Exp. Immunol. 96:48.
7. + T lymphocytes of common variable immunodeficiency (CVID) patients. Clin. Exp. Immunol. 110:174.
8. Zielen, S., P. Bauscher, D. Hofmann, and S. C. Meuer. 1993. Interleukin 10 and immune restoration in common variable immunodeficiency. Lancet 342:750.
9. Sneller, M. C., and W. Strober. 1990. Abnormalities of lymphokines gene expression in patients with common variable immunodeficiency. J. Immunol. 144:3762.
10. Di Renzo, M., Z. Zhou, I. George, K. Becker, and C. Cunningham-Rundles. 2000. Enhanced apoptosis of T cells in CVID: role of defective CD28 co-stimulation. Clin. Exp. Immunol. 120:503.
11. Cunningham-Rundles, C., W. E. Brandeis, D. J. Pudifin, N. K. Day, and R. A. Good. 1981. Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease. Clin. Exp. Immunol. 45:299.
12. Farrant, J., G. Spickett, N. Matamoros, D. Copas, M. Hernandez, M. North, H. Chapel, and A. D. Webster. 1994. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency. Immunodeficiency 5:159.
13. Pandolfi, F., G. Corte, I. Quinti, M. Fiorilli, A. Frieligsdorf, A. Bargellesi, and F. Aiuti. 1983. Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinemia. Clin. Exp. Immunol. 51:470.
14. Pandolfi, F., L. Trentin, J. E. San Martin, J. T. Wong, J. T. Kurnick, and R. A. Moscicki. 1992. T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis. Clin. Exp. Immunol. 89:198.
15. Spickett, G. P., J. Farrant, M. E. North, J. G. Zhang, L. Morgan, and A. D. B. Webster. 1997. CVID: how many diseases. Immunol. Today 18:325.
16. Levy, Y., N. Gupta, F. Le Deist, C. Garcia, A. Fischer, J. C. Weill, and C. A. Reynaud. 1998. Defect in IgV gene somatic hypermutation in common variable immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 95:13135.
17. North, M. E., K. Ivory, M. Funauchi, A. D. B. Webster, A. C. Lane, and J. Farrant. 1996. Intracellular cytokine production by human CD4 and CD8 T cells from normal and immunodeficient donors using directly conjugated anticytokine antibodies and three-colour flow cytometry. Clin. Exp. Immunol. 105:517.
18. Guazzi, V., F. Aiuti, I. Mezzaroma, F. Mazzetta, G. Andolfi, A. Mortellaro, M. Pierdominici, R. Fantini, M. Marziali, and A. Aiuti. 2002. Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles. Clin. Exp. Immunol. 129:346.
19. Dexter, T. M., and L. G. Lajtha. 1974. Proliferation of haemopoietic stem cells in vitro. Br. J. Haematol. 28:525.
20. Gordon, M. Y., G. P. Ripley, S. M. Watt, and M. F. Greaves. 1987. Compartmentalization of a haematopoietic growth factor (GM-CSF.) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403.
21. Kimmig, S., G. K. Przybylski, C. A. Schmidt, K. Laurisch, B. Mowes, A. Radbruch, and A. Thiel. 2002. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195:789.
22. Sutherland, H., P. M. Lansdorp, D. H. Henkelman, A. C. Eaves, and C. J. Eaves. 1990. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Nat 4. Acad. Sci. USA 87:3584.
23. Cline, M. J., and D. W. Golde. 1978. Immune suppression of hematopoiesis. Am. J. Med. 64:301.
24. Means, R. T. 1995. Pathogenesis of the anemia of chronic disease: a cytokine mediated anemia. Stem Cells 13:32.
25. Verfaillie, C. M. 1996. Chemokines as inhibitors of hematopoietic progenitors. J. Lab. Clin. Med. 127:148.
26. Matloubian, M., C. G. Lo, G. Cinamon, M. J. Lesneski, Y. Xu, V. Brinkmann, M. L. Allende, R. L. Proia, and J. G. Cyster. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on SIP receptor 1. Nature 427:355.
27. Zanussi, S., C. Simonelli, M. T. Bortolin, M. D'Andrea, C. Crepaldi, E. Vaccher, G. Nasti, D. Politi, L. Barzan, U. Tirelli, and P. De Paoli. 1999. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or with HAART + IL-2. Clin. Exp. Immunol. 116:486.
28. Cunningham-Rundles, C., C. Bodian, H. D. Ochs, S. Martin, M. Reiter-Wong, and Z. Zhuo. 2001. Long-term low dose IL-2 enhances immune function in common variable immunodeficiency. Clin. Immunol. 100:181.
29. Keller, J. R., F. W. Ruscetti, and K. J. Grzegorzewski. 1997. Transforming growth factor-α, tumor necrosis factor-α, and macrophage inflammatory protein-1α are bidirectional regulators of hematopietic cell growth. In Colony-Stimulating Factors: Molecular and Cellular Biology. J.M. Garland, P.J. Quesenberry, and D.J. Hilton, eds. Marcel Dekker, New York, p. 445.
30. Nagafuji, K., T. Shibuya, M. Harada, S. Mizuno, K. Takenaka, T. Miyamoto, T. Okamura, H. Gondo, and Y. Niho. 1995. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883.
31. + cells. Br. J. Haematol. 97:356.
32. Dybedal, I., D. Bryder, A. Possum, L. S. Rusten, and S. E. Jacobsen. 2001. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood 98:1782.
33. Roberts, R., J. Gallagher, E. Spooncer, T. D. Allen, F. Bloomfield, and T. M. Dexter. 1988. Heparin sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332:376.
34. Sudo, T., M. Ito, Y. Ogawa, M. Iizuka, H. Kodama, T. Kunisada, S. Hayashi, M. Ogawa, K. Sakai, and S. Nishikawa. 1989. Interleukin 7 production and function in stromal cell-dependent B cell development. J. Exp. Med. 170:333.
35. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 96:8732.
36. Mackall, C. L., T. J. Fry, C. Bare, P. Morgan, A. Galbraith, and R. E. Cress. 2001. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone-marrow transplantation. Blood 97:1491.
37. Opferman, J. T., A. Letai, C. Beard, M. D. Sordnelli, C. C. Ong, and S. J. Korsmeyer. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426:671.